問卷

TPIDB > Search Result

Search Result

篩選

List

10Cases

2023-12-01 - 2027-03-01

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2024-08-01 - 2031-12-31

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2025-03-30 - 2031-12-31

Others

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2024-08-01 - 2031-12-31

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2021-03-31 - 2025-01-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting3Sites

Terminated1Sites

2026-02-23 - 2032-12-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2024-12-01 - 2030-03-19

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2024-12-02 - 2030-12-09

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2023-10-17 - 2028-12-31

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2018-03-01 - 2020-12-29

Phase I/II

An Open-Label Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
  • Condition/Disease

    Advanced Stage Newly Diagnosed Hodgkin Lymphoma

  • Test Drug

    ADCETRIS

Participate Sites
2Sites

Recruiting1Sites

Terminated1Sites